TLR3 and central nervous system cancer: It was also reported that cytokine and toll-like receptor-3 agonist (Poly-ICLC) facilitate ACT trafficking to the tumor site, thus helping to kill tumor cells and prolong the survival of glioma-bearing animals [34].